Embelin-a drug of antiquity: Shifting the paradigm towards modern medicine

Expert Opinion on Investigational Drugs

Volumn 23, Issue 3, 2014, Pages 427-444

  Poojari, Radhika ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

Author keywords

Embelin; Ethnomedicinal uses; Molecular targets; Pharmacotherapeutics; Vidanga

Indexed keywords

ANIMALS; BENZOQUINONES; HUMANS; PHYTOTHERAPY; TREATMENT OUTCOME;

EID: 84894069845     PISSN: 13543784     EISSN: 17447658     Source Type: Journal    
DOI: 10.1517/13543784.2014.867016     Document Type: Article

References (120)

1. Anonymous. Pharmacognosy of indigenous drugs. Central Council for Research in Ayurveda and Siddha, New Delhi; 1999. p. 1046-61
2. Chopra RN, Chopra IC, Handa K, et al. Indigenous drugs of India. Dhur UN and Sons Press; Calcutta: 1958. p. 597; 672
3. Sharma PC, Yelne MB, Dennis TJ. Database on medicinal plants used in ayurveda and siddha. Central Council for Research in Ayurveda and Siddha; New Delhi: 2002. p. 478-99
4. Gupta OP, Ali MM, Ray GBJ, et al. Some pharmacological investigations of embelin and its semisynthetic derivatives. Indian J Physiol Pharmacol 1977;21:31-9
5. Rao CB, Venkateswaralu V. Vilangin a new constituent of Embelia ribes. Curr Sci 1961;30:250-60
6. Rao TVP, Venkateswarlu V. Chemical examination of Embelia ribes. IV: Condensation reactions of embelin with primary amines. Tetrahedron 1964;20:969-71
7. Hao K, Ali M, Siddiqui AW. New compounds from the seeds of Embelia ribes Burm. Pharmazie 2005;60:69-71
8. Cherutoi JK, Cheruiyot LL, Kiprono CP. Synthesis and characterization of zinc(II) and copper(II) complexes of embelin. Bull Chem Soc Ethiop 2005;19:295-9
9. Lamblin M, Sallustrau A, Commandeur C, et al. Synthesis and biological evaluation of hydrophilic embelin derivatives. Tetrahedron 2012;68:4655-63
10. Lin Z, Jensen JK, Hong Z, et al. Structural insight into inactivation of plasminogen activator inhibitor-1 by a small-molecule antagonist. Chem Biol 2013;20:253-61
11. Nikolovska-Coleska Z, Xu L, Hu Z, et al. Discovery of embelin as a cell-permeable small-molecular weight inhibitor of XIAP through structurebased computational screening of a traditional herbal medicine three-dimensional structure database. J Med Chem 2004;47:2430-40
12. Chen J, Nikolovska-Coleska Z, Wang G, et al. Design, synthesis, and characterization of new embelin derivatives as potent inhibitors of X-linked inhibitor of apoptosis protein. Bioorg Med Chem Lett 2006;16:5805-8
13. Pena R, Jimenez-Alonso S, Feresin G, et al. Multicomponent synthesis of antibacterial dihydropyridin and dihydropyran embelin derivatives. J Org Chem 2013;78(16):7977-85
14. Rao CB, Venkateshwarlu V. Estimation of embelin from Embelia ribes Burm.f. and Embelia robusta. Indian J Pharm 1962;24:262
15. Pal SK, Mukherjee PK, Saha BP, et al. Estimation embelin in Embelia ribes Burm.F. (Myrsinaceae) and in formulation by spectrophotometric method. Res Ind 1995;40:118-20
16. Eapen Saumy MS, Grampurohit ND. Chemical evaluation of Navyasa churna. Indian Drugs 2002;39:101-5
17. Kukkar R, Saluja AK, Shah UD. Estimation of Embelin and Strychnine in Krimimudgara rasa by HPTLC method. Int J Pharm Qual Assur 2010;2:1-4
18. Ganesan B, Perumal P, Manickam V, et al. Optimization of extraction conditions for embelin in Embelia ribes by UV spectrophotometry. Arch Apll Sci Res 2010;2:49-53
19. Poojari R. Phytochemical fingerprinting, cytotoxic, antimicrobial, antitubercular, antimycotic potentials of Sida rhombifolia ssp. retusa and Embelia tsjeriam-cottam. Asia Pac J Life Sci 2011;4:201-14
20. Shelar R, Maurya C, Tekale P, et al. Embelin - An HPLC method for quantitative estimation in Embelia ribes Burm. F. Int J Pharm Clin Res 2009;1:146-9
21. Madhavan SN, Arimboor R, Arumughan C. RP-HPLC-DAD method for the estimation of embelin as marker in Embelia ribes and its polyherbal formulations. Biomed Chromatogr 2011;25:600-5
22. Chauhan SK, Singh BP, Agrawal S. Determination of embelin from Embelia ribes by high performance thin layer chromatography. Indian Drugs 1999;36:41-3
23. Patel RK, Patel VR, Patel MG. Development and validation of a RP-HPLC method for the simultaneous determination of Embelin, Rottlerin and Ellagic acid in Vidangadi churna. J Pharm Anal 2012;2:366-71
24. Srinivas N, Narsimha Reddy Y, Goverdhan P, et al. Development and validation of HPLC method for determination of Embelin in rat plasma and its application to pharmacokinetic study. J Pharm Res 2011;4:3660-3
25. Zutshi U, Sharma SC, Kaul JL, et al. Kinetic fate of potassium embelate, a non-narcotic centrally acting analgesic after oral and intravenous administration. Pharmacology 1990;40:179-84
26. Chitra M, Sukumar E, Suja V, et al. Antitumour, anti inflammatory and analgesic property of embelin, a plant product. Chemother 1994;40:109-13
27. Kalyan Kumar G, Dhamotharan R, Kulkarni NM, et al. Embelin reduces cutaneous TNF-A level and ameliorates skin edema in acute and chronic model of skin inflammation in mice. Eur J Pharmacol 2011;662:63-9
28. Mahendran S, Badami S, Ravi S, et al. Synthesis and evaluation of analgesic and anti-inflammatory activities of most active free radical scavenging derivatives of embelin-A structure-Activity relationship. Chem Pharm Bull (Tokyo) 2011;59:913-19
29. Mahendran S, Badami S, Ravi S, et al. Antioxidant, analgesic and antiinflammatory properties of new ninhydrin adduct of embelin. Pharm Chem J 2011;45:547-51
30. Kumara Swamy HM, Krishna V, et al. Wound - healing activity of embelin isolated from ethanol extract of leaves of Embelia ribes Burm. J Ethnopharmacol 2007;109:529-34
31. Deshmukh PT, Gupta VB. Embelin accelerates cutaneous wound healing in diabetic rats. J Asian Nat Prod Res 2013;15:158-65
32. Schaible AM, Traber H, Temml V, et al. Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 by the anticarcinogenic and anti-inflammatory agent embelin. Biochem Pharmacol 2013;86:476-86
33. Swamy RN, Gnanamani A, Shanmugasamy S, et al. Bioinformatics in crosslinking chemistry of collagen with selective cross linkers. BMC Res Notes 2011;4:399
34. Arora RB, Ghatak N, Gupta SP. Antifertility activity of Embelia ribes. J Res Indian Med 1971;6:107-11
35. Purandare TV, Kholkute SD, Gurjar A, et al. Semen analysis and hormonal levels in bonnet macaques administered Embelia ribes berries, an indigenous plant having contraceptive activity. Indian J Exp Biol 1979;17:935-7
36. Singh IP, Bharate SB, Singh A, et al. Fate of embelin in Pippalyadi yoga, an ayurvedic oral contraceptive: Structure of embelin-borax complex and evaluation of anti-fertility activity. Indian J Chem 2007;46B:320-5
37. Radhakrishnan N, Alam M. Antifertility activities of embelin in albino rats. Indian J Exp Biol 1975;13:70-1
38. Prakash AO. Antifertility investigations on embelin: An oral contraceptive of plants origin. Part-I: Biological properties. Planta Med 1981;41:259-66
39. Rathinam K, Kumari S, Ramiah N. Studies on the antifertility activity of embelin. J Res Ind Med Yoga Homeop 1976;11:84-90
40. Seth SD, Johri N, Sundaram KR. Antispermatogenic effect of embelin from Embelia ribes. Indian J Pharmacol 1982;14:207-11
41. Agarwal S, Chauhan S, Mathur R. Antifertility effects of embelin in male rats. Andrologia 1986;18:125-31
42. Gupta S, Sanyal SN, Kanwar U. Antispermatogenic effect of embelin, a plant benzoquinone, on male albino rats in vivo and in vitro. Contraception 1989;39:307-20
43. Dixit SK, Bhargava SK. Reversible contraception-like activity of embelin in male dogs (Canis indicus Linn). Andrologia 1983;15:486
44. Githui EK, Makawiti DW, Midiwo JO. Changes in the concentrations of testosterone, luteinising hormone and progesterone associated with administration of embelin. Contraception 1991;44:311-17
45. Krishnaswamy M, Purushothaman KK. Antifertility properties of Embelia ribes: (Embelin). Indian J Exp Biol 1980;18:1359-60
46. Johri RK, Pahwa GS, Sharma SC, et al. Determination of estrogenic/ antiestrogenic potential of antifertility substances using rat uterine peroxidase assay. Contraception 1991;44:549-57
47. Wango EO. Anti-fertility effects of embelin in female Sprague-Dawley rats may be due to suppression of ovarian function. Acta Biol Hung 2005;56:1-9
48. Chandra R, Agarwal S, Bajaj S, et al. A clinical trial of gasex in gastrointestinal disorders in post-operative gastro-intestinal symptoms. Probe 1978;27:330-3
49. Gupta S, Sanyal SN, Kanwar U. Changes in glucose/amino acid/calcium uptake and brush-border membraneassociated enzymes in rat small intestine after the administration of embelin (plant benzoquinone), an antifertility agent. J Nutr Sci Vitaminol (Tokyo) 1990;36:153-64
50. Gupta S, Sanyal S, Kanwar U. Effects of embelin, a male antifertility agent, on absorptive and digestive functions of rat intestine. J Ethnopharmacol 1991;33:203-12
51. Thippeswamy BS, Mahendran S, Biradar MI, et al. Protective effect of embelin against acetic acid induced ulcerative colitis in rats. Eur J Pharmacol 2011;654:100-5
52. Kumar GK, Dhamotharan R, Kulkarni NM, et al. Embelin ameliorates dextran sodium sulfate-induced colitis in mice. Int Immunopharmacol 2011;11:724-31
53. Poojari R, Gupta S, Maru G, et al. Chemopreventive and hepatoprotective effects of embelin on Nnitrosodiethylamine and carbon tetrachloride induced preneoplasia and toxicity in rat liver. Asian Pac J Cancer Prev 2010;11:1015-20
54. Singh D, Singh R, Singh P, et al. Effect of embelin on lipid peroxidation and free radical scavenging activity against liver damage in rats. Basic Clin Pharmacol Toxicol 2009;105:243-8
55. Gupta S, Sanyal SN, Kanwar U. Effects of embelin, an antifertility agent, on the lipid metabolism of male albino rats. Fitoterapia 1989;60:331-8
56. Chitra M, Shyamala Devi CS, Viswanathan S, et al. Effect of Embelin on lipid profile in transplanted fibrosarcoma in rats. Indian J Pharmacol 2003;35:241-4
57. Jagadeesh MC, Sreepriya M, Bali G, et al. Biochemical studies on the effect of curcumin and embelin during Nnitrosodiethylamine/ Phenobarbital induced-hepatocarcinogenesis in Wistar rats. Afr J Biotechnol 2009;8:4618-22
58. Chaudhari HS, Bhandari U, Khanna G. Preventive effect of embelin from Embelia ribes on lipid metabolism and oxidative stress in high-fat diet-induced obesity in rats. Planta Med 2012;78:651-7
59. Wu H, Panakanti R, Li F, et al. XIAP gene expression protects beta-cells and human islets from apoptotic cell death. Mol Pharmacol 2010;7:1655-66
60. Mahendran S, Maithili V, Badami S. Evaluation of antidiabetic effect of embelin from Embelia ribes in alloxan induced diabetes in rats. Biomed Prev Nutr 2011;1:25-31
61. Gupta R, Sharma AK, Sharma MC, et al. Antioxidant activity and protection of pancreatic beta-cells by embelin in streptozotocin-induced diabetes. J Diabetes 2012;4:248-56
62. Naik SR, Niture NT, Ansari AA, et al. Anti-diabetic activity of embelin: Involvement of cellular inflammatory mediators, oxidative stress and other biomarkers. Phytomedicine 2013;20:797-804
63. Gandhi GR, Stalin A, Balakrishna K, et al. Insulin sensitization via partial agonism of PPARgamma and glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway by embelin in type 2 diabetic rats. Biochim Biophys Acta 2013;1830:2243-55
64. Sun Y, Wang D, Ye F, et al. Elevated cell proliferation and VEGF production by high-glucose conditions in Muller cells involve XIAP. Eye (Lond) 2013;27(11):1299-307
65. Thippeswamy BS, Nagakannan P, Shivasharan BD, et al. Protective effect of embelin from Embelia ribes Burm. against transient global ischemia-induced brain damage in rats. Neurotox Res 2011;20:379-86
66. Mahendran S, Thippeswamy BS, Veerapur VP, et al. Anticonvulsant activity of embelin isolated from Embelia ribes. Phytomedicine 2011;18:186-8
67. Modak R, Basha J, Bharathy N, et al. Probing p300/CBP associated factor (PCAF)-dependent pathways with a small molecule inhibitor. ACS Chem Biol 2013;8:1311-23
68. Siegel C, Li J, Liu F, et al. miR-23a regulation of X-linked inhibitor of apoptosis (XIAP) contributes to sex differences in the response to cerebral ischemia. Proc Natl Acad Sci USA 2011;108:11662-7
69. Hill CA, Alexander ML, McCullough LD, et al. Inhibition of X-linked inhibitor of apoptosis with embelin differentially affects male versus female behavioral outcome following neonatal hypoxia-ischemia in rats. Dev Neurosci 2011;33:494-504
70. Danquah M, Duke C, Patil R, et al. Combination therapy of antiandrogen and XIAP inhibitor for treating advanced prostate cancer. Pharm Res 2012;29:2079-91
71. Obiol-Pardo C, Granadino-Roldán JM, Rubio-Martinez J. Protein-protein recognition as a first step towards the inhibition of XIAP and Survivin anti-Apoptotic proteins. J Mol Recognit 2008;21:190-204
72. Viault G, Babu KS, Gautier F, et al. Hemisynthesis of selected Embelin analogues and investigation of their proapoptotic activity against cancer cells. Med Chem 2013;9(8):1028-34
73. Chitra M, Shyamala Devi CS. Protective action of embelin against lipid peroxidation on tumor bearing rats. Fitoterapia 1994;15:317-21
74. Chitra M, Sukumar E, Shyamala Devi CS. [3H] - Thymidine uptake and lipid peroxidation by tumor cells on embelin treatment: An in vitro study. Oncology 1995;52:66-8
75. Joshi R, Kamat JP, Mukherjee T. Free radical scavenging reactions and antioxidant activity of embelin: Biochemical and pulse radiolytic studies. Chem Biol Interact 2007;167:125-34
76. Landa P, Kutil Z, Temml V, et al. Redox and non-redox mechanism of in vitro cyclooxygenase inhibition by natural quinones. Planta Med 2012;78:326-33
77. Joshi R, Ghanty TK, Mukherjee T. Formation of semiquinone radical in the reaction of embelin (2,5-dihydroxy-3-undecyl-1,4-benzoquinone) with reductants as well as oxidants. Characterization by pulse radiolysis and structure investigation by quantum chemical study. J Mol Struct 2009;928:46-53
78. Allensworth JL, Aird KM, Aldrich AJ, et al. XIAP inhibition and generation of reactive oxygen species enhances TRAIL sensitivity in inflammatory breast cancer cells. Mol Cancer Ther 2012;11:1518-27
79. Aird KM, Ding X, Baras A, et al. Trastuzumab signaling in ErbB2-overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expression. Mol Cancer Ther 2008;7:38-47
80. Aird KM, Ghanayem RB, Peplinski S, et al. X-linked inhibitor of apoptosis protein inhibits apoptosis in inflammatory breast cancer cells with acquired resistance to an ErbB1/ 2 tyrosine kinase inhibitor. Mol Cancer Ther 2010;9:1432-42
81. Li Y, Li D, Yuan S, et al. Embelin-induced MCF-7 breast cancer cell apoptosis and blockade of MCF-7 cells in the G2/M phase via the mitochondrial pathway. Oncol Lett 2013;5:1005-9
82. Mori T, Doi R, Kida A, et al. Effect of the XIAP inhibitor embelin on TRAILinduced apoptosis of pancreatic cancer cells. J Surg Res 2007;142:281-6
83. Siegelin MD, Gaiser T, Siegelin Y. The XIAP inhibitor Embelin enhances TRAIL -mediated apoptosis in malignant glioma cells by down-regulation of the short isoform of FLIP. Neurochem Int 2009;55:423-30
84. Wang A, Zhang B, Zhang J, et al. Embelin-induced brain glioma cell apoptosis and cell cycle arrest via the mitochondrial pathway. Oncol Rep 2013;29:2473-8
85. Cheng YJ, Jiang HS, Hsu SL, et al. XIAP-mediated protection of H460 lung cancer cells against cisplatin. Eur J Pharmacol 2010;627:75-84
86. Xu M, Cui J, Fu H, et al. Embelin derivatives and their anticancer activity through microtubule disassembly. Planta Med 2005;71:944-8
87. Hu R, Wu B, Zhang GJ, et al. Effect of Embelin on proliferation, differentiation and aopotosis of HL-60 cells. Zhonghua Xue Ye Xue Za Zhi 2010;31:442-5
88. Hu R, Zhu K, Li Y, et al. Embelin induces apoptosis through downregulation of XIAP in human leukemia cells. Med Oncol 2011;28:1584-8
89. Srinivas K, Mahesh Ch, Jagadeesh N. Anti-mitotic activity of embelin derivatives. Int J Phytopharmacol 2010;1:97-102
90. Newell AM, Yousef GG, Lila MA, et al. Comparative in vitro bioactivities of tea extracts from six species of Ardisia and their effect on growth inhibition of HepG2 cells. J Ethnopharmacol 2010;130:536-44
91. Taghiyev A, Sun D, Gao ZM, et al. Embelin-induced apoptosis of HepG2 human hepatocellular carcinoma cells and blockade of HepG2 cells in the G2/M phase via the mitochondrial pathway. Exp Ther Med 2012;4:649-54
92. Che Y, Ye F, Xu R, et al. Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma. Am J Pathol 2012;180:1798-807
93. Joy B, Sivadasan R, Abraham TE, et al. Lysosomal destabilization and cathepsin B contributes for cytochrome c release and caspase activation in embelininduced apoptosis. Mol Carcinog 2010;49:324-36
94. Schmidt K, Martens-Lobenhoffer J, Meinitzer A, et al. Activation of endothelial nitric oxide synthase by the pro-Apoptotic drug embelin: Striking discrepancy between nitric oxidemediated cyclic GMP accumulation and L-citrulline formation. Nitric Oxide 2010;22:281-9
95. Heo JY, Kim HJ, Kim SM, et al. Embelin suppresses STAT3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase PTEN. Cancer Lett 2011;308:71-80
96. Han JM, Kim WB, Yim JH, et al. The effect of a XIAP inhibitor, embelin, on apoptosis of thyroid cancer cell lines. Cancer Res 2012;72(Suppl 8):1709
97. Jehan Z, Abdul Rahman Al-obaisi K, Uddin S, et al. Embelin induces autophagy in ovarian cancer cells. Cancer Res 2012;72(Suppl 8):2265
98. Kim SW, Kim SM, Bae H, et al. Embelin inhibits growth and induces apoptosis through the suppression of Akt/mTOR/S6K1 signaling cascades. Prostate 2013;73:296-305
99. Ahn KS, Sethi G, Aggarwal BB. Embelin, an inhibitor of X chromosomelinked inhibitor-of-Apoptosis protein, blocks nuclear factor-kB (NF-kB) signaling pathway leading to suppression of NF-kB-regulated antiapoptotic and metastatic gene products. Mol Pharmacol 2007;71:209-19
100. Park SY, Lim SL, Jang HJ, et al. Embelin induces apoptosis in human glioma cells through inactivating NF-kB. J Pharmacol Sci 2013;121:192-9
101. Mareninova OA, Sung KF, Hong P, et al. Cell death in pancreatitis: Caspases protect from necrotizing pancreatitis. J Biol Chem 2006;281:3370-81
102. Sreepriya M, Bali G. Chemopreventive effects of embelin and curcumin against N-nitrosodiethylamine/phenobarbitalinduced hepatocarcinogenesis in Wistar rats. Fitoterapia 2005;76:549-55
103. Sreepriya M, Bali G. Effects of administration of embelin and curcumin on lipid peroxidation, hepatic glutathione antioxidant defense and hematopoietic system during N-nitrosodiethylamine/ Phenobarbital-induced hepatocarcinogenesis in Wistar rats. Mol Cell Biochem 2006;84:49-55
104. Dai Y, Qiao L, Chan KW, et al. Peroxisome proliferator-Activated receptor-g contributes to the inhibitory effects of embelin on colon carcinogenesis. Cancer Res 2009;69:4776-83
105. Dai Y, Liu M, Tang W, et al. Molecularly targeted radiosensitization of human prostate cancer by modulating inhibitor of apoptosis. Clin Cancer Res 2008;14:1-10
106. Dai Y, Desano J, Qu Y, et al. Natural IAP inhibitor Embelin enhances therapeutic efficacy of ionizing radiation in prostate cancer. Am J Cancer Res 2011;1:128-43
107. Lunardi A, Ala U, Epping MT, et al. A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. Nat Genet 2013;45:747-55
108. Radhakrishnan N, Gnanamani A, Prasad NR, et al. Inhibition of UVBinduced oxidative damage and apoptotic biochemical changes in human lymphocytes by 2,5-dihydroxy-3-undecyl-1,4-benzoquinone (embelin). Int J Radiat Biol 2012;88:575-82
109. Lu J, Huang Y, Zhao W, et al. PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers. Biomaterials 2013;34:1591-600
110. Huang Y, Lu J, Gao X, et al. PEG-derivatized embelin as a dual functional carrier for the delivery of paclitaxel. Bioconjugate Chem 2012;23:1443-51
111. Pathan RA, Bhandari U. Preparation and characterization of embelin-phospholipid complex as effective drug delivery tool. J Incl Phenom Macrocycl Chem 2011;69:139-47
112. Li F, Danquah M, Mahato RI. Synthesis and characterization of amphiphilic lipopolymers for micellar drug delivery. Biomacromolecules 2010;11:2610-20
113. Danquah M, Li F, Duke C, et al. Micellar delivery of bicalutamide and embelin for treating prostate cancer. Pharm Res 2009;26:2081-92
114. Cortez Tornello PR, Feresin GE, Tapia A, et al. Dispersion and release of embelin from electrospun, biodegradable, polymeric membranes. Polymer J 2012;44:1105-11
115. Vidang. Available from: Http://www. ayurvedaconsultants.com/images/ doctor/ ayurveda/ayurvedic-herb-vidang.aspx [Last accessed 2 May 2013]
116. Vidangasava. Available from: Http://www. kayaguru.com/Ayurveda-Default. aspx? filename=Ayurveda/Bhaishajya/Asava [Last accessed 2 May 2013]
117. Anonymous. The ayurvedic pharmacopoeia of India. Part-I. Ministry of Health and Family Welfare, Department of AYUSH, Government of India; New Delhi: 1989. p. 123-4
118. Anonymous. Indian herbal pharmacopoeia. A joint publication of Regional Research Laboratories (CSIR) Jammu Tawi and Indian Drugs Manufacturer's Association; Mumbai: 2002. p. 206-13
119. Prakash AO. Short term toxicity of embelin in female rats. Phytother Res 1994;8:257-64
120. Gupta S, Kanwar U. Biodistribution of embelin a benzoquinone of male antifertility potential. Fitoterapia 1991;62:419-25